Welcome to Enabled Therapeutics, formerly known as Mercaptor. We are excited to share that all information on our website including our Capton intellectual property and approach is now managed by the founders of Enabled Therapeutics. This marks an exciting new phase in the development of Captons, and we look forward to advancing therapeutic solutions. All historical news below refers to Mercaptor, our former name.
Mercaptor’s 5th Annual Rare Disease Day Virtual 5K
On February 25, 2020, the Mercaptor Discoveries team participated in the 5th Annual Rare Disease Day Virtual Race by walking a 5K. The walk was
Mercaptor Hopes Fighting Traumatic Brain Injury Will Help Fight Homelessness
Mercaptor Discoveries is developing drugs and therapies that we hope can be a major tool in the battle against Traumatic Brain Injury (TBI). While most
Mercaptor in the ALEA Journal
We happy to be picked up by the ALEA Journal: https://issuu.com/aleajournal/docs/alea_journal_with_new_logo_position/13 For more on the ALEA Journal, click here.
Ground Breaking CTE Research May Save the Game of Football
Can Mercaptor Discoveries research save the game of football? These questions and more are addressed in this recent article from our friends at SB Nation.
Mercaptor Discoveries Announces Preclinical Program in Epilepsy
NOVATO, Calif., Jan. 9, 2020 /PRNewswire/ — Mercaptor Discoveries (Mercaptor), a company developing therapeutic agents active exclusively at the site of injury, announced the advancement of its
Watch CEO Sara Isbell Speak at the VII Private Investment Forum Worldwide in Zurich
The VII Zurich Private Investment Forum Worldwide was held on April 9, 2019 in Baur Au Lac, Zurich, Switzerland. Mercaptor Discoveries’ CEO Sara Isbell presented